StonvexLoading…
StonvexCore line items from SAFE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $385.55M | $365.69M | $352.58M | $270.31M |
Operating Income | $100.90M | $87.08M | $-77.08M | $135.63M |
Net Income | $114.47M | $105.76M | $-54.97M | $135.42M |
EPS (Diluted) | $1.59 | $1.48 | $-0.82 | $2.17 |
Total Assets | $7.25B | $6.90B | $6.55B | $5.85B |
Total Liabilities | $4.81B | $4.53B | $4.25B | $3.69B |
Cash & Equivalents | $21.70M | $8.35M | $18.76M | $20.07M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 71.76M | 71.44M | 71.08M | 62.40M |